Biora Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Biora Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 99% to $4,000. Profit margin reached -3102875%. Total operating expenses were $67,147,000.
Profit Margin
| 2018 | 127.97M | -129.10M | -100.88% |
|---|---|---|---|
| 2019 | 143.98M | -148.03M | -102.81% |
| 2020 | 74.31M | -192.52M | -259.08% |
| 2021 | 1.24M | -178.52M | -14316.04% |
| 2022 | 305K | -48.83M | -16009.84% |
| 2023 | 4K | -124.11M | -3102875% |
PROG Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 4K | 305K | 1.24M | 74.31M | 143.98M | 127.97M |
Cost of revenue | 0 | 907K | 1.43M | 93.43M | 100.49M | 92.07M |
Gross profit | 4K | -602K | -190K | -19.12M | 43.49M | 35.89M |
Operating exp. | ||||||
Research and development | 29.83M | 24.04M | 45.78M | 47.74M | 63.4M | 48.71M |
Selling and marketing | 0 | 0 | 4.75M | 52.88M | 58.88M | 50.18M |
Total operating expenses | 67.14M | 62.08M | 119.08M | 176.06M | 183.61M | 150.13M |
Operating income | -67.14M | -61.78M | -117.83M | -195.18M | -140.11M | -114.23M |
Other income (expenses), net | -57.28M | 12.53M | -60.80M | -34.99M | -8.62M | -2.32M |
Income before tax | -124.42M | -49.25M | -178.64M | -230.06M | -148.74M | -123.85M |
Income tax expense | -90K | -420K | -119K | -37.53M | -706K | 5.25M |
Net income | -124.11M | -48.83M | -178.52M | -192.52M | -148.03M | -129.10M |
Earnings per share | ||||||
Basic EPS | -7.87 | -6.4 | -46.42 | -86.3 | -80.17 | -119.71 |
Diluted EPS | -7.87 | -6.4 | -46.42 | -86.3 | -80.17 | -119.71 |
| Data source | Data source | Data source | Data source |